In Jerusalem's Hadassah Ein Kerem hospital, an experiment was conducted to treat patients with COVID-19 using biological cells taken from healthy people, Channel 9 Israel wrote.
"On the eve of September 30, a fifth of five critically ill patients were discharged after receiving innovative treatment in the first clinical trial of this kind," the report said.
The test on "covid" patients was carried out with the approval of the Israeli Ministry of Health. The experiment involved five seriously ill patients, two of whom were already in critical condition.
The drug, called Alostra, was developed on the basis of research by the head of the department of internal medicine and the head of the red zone of Hadassah, Professor Dror Mevrurah, in conjunction with the biotechnology company Analybex Therapeutics.
Previously, this drug was successfully tested on ten patients with sepsis.
As we reported before, the massive inoculation from coronavirus in Ukraine is not supposed to begin in Ukraine before May 2021